(Q53347956)

13 May 2018

title

MTH-68/H oncolytic viral treatment in human high-grade gliomas. (English)

1 reference

13 May 2018

1 reference

L K Csatary

1 reference

13 May 2018

G Gosztonyi

1 reference

13 May 2018

J Szeberenyi

1 reference

13 May 2018

Z Fabian

1 reference

13 May 2018

V Liszka

1 reference

13 May 2018

B Bodey

1 reference

13 May 2018

C M Csatary

1 reference

13 May 2018

publication date

1 March 2004

1 reference

13 May 2018

Journal of Neuro-Oncology

published in

1 reference

13 May 2018

volume

1 reference

13 May 2018

issue

1-2

1 reference

13 May 2018

page(s)

83-93

1 reference

13 May 2018

Molecular therapy for glioblastoma

cites work

1 reference

12 December 2020

Newcastle disease virus selectively kills human tumor cells

1 reference

12 December 2020

The biology of astrocytoma: lessons learned from chronic myelogenous leukemia--hypothesis

1 reference

12 December 2020

Gene therapy of glioblastomas: from suicide to homicide

1 reference

12 December 2020

Favorable outcome of giant cell glioblastoma in a child. Report of an 11-year survival period

1 reference

12 December 2020

Immunohistochemical detection of p53 protein expression in various childhood astrocytoma subtypes: significance in tumor progression

1 reference

12 December 2020

Retinoic acid enhances killing of neuroblastoma cells by Newcastle disease virus

1 reference

12 December 2020

1 reference

12 December 2020

A statistical study of brain tumors in the neurosurgical clinics in Japan

1 reference

12 December 2020

Immune responses in glioblastoma: an avenue to effective cancer therapy or a mere epiphenomenon?

1 reference

12 December 2020

Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H).

1 reference

12 December 2020

Induction of apoptosis by a Newcastle disease virus vaccine (MTH-68/H) in PC12 rat phaeochromocytoma cells

1 reference

12 December 2020

Immunobiology of human gliomas

1 reference

12 December 2020

Role of gemistocytes in astrocytoma progression.

1 reference

12 December 2020

Attenuated veterinary virus vaccine for the treatment of cancer.

1 reference

12 December 2020

Molecular genetic analysis of giant cell glioblastomas

1 reference

12 December 2020

Histopathology, classification, and grading of gliomas

1 reference

12 December 2020

Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.

1 reference

12 December 2020

Genetically engineered HSV in the treatment of glioma: a review

1 reference

12 December 2020

Subsets of glioblastoma multiforme defined by molecular genetic analysis

1 reference

12 December 2020

Live viruses in cancer treatment

1 reference

12 December 2020

Newcastle disease virus-induced apoptosis in PC12 pheochromocytoma cells

1 reference

12 December 2020

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas

1 reference

12 December 2020

Proliferation index as a predictor of prognosis in malignant gliomas of childhood

1 reference

12 December 2020

Apoptosis in chicken embryo fibroblasts caused by Newcastle disease virus

1 reference

12 December 2020

Re: Scientific interest in newcastle disease virus is reviving

1 reference

12 December 2020

VIRUSES IN THE TREATMENT OF CANCER

1 reference

12 December 2020

Viruses in the treatment of cancer

1 reference

12 December 2020

Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion

1 reference

12 December 2020

Immunobiology of primary intracranial tumors. Part 8: Serological responses to active immunization of patients with anaplastic gliomas

1 reference

12 December 2020

Malignant glioma: should chemotherapy be overthrown by experimental treatments?

1 reference

12 December 2020

Scientific interest in Newcastle disease virus is reviving

1 reference

12 December 2020

Practical guidelines for the treatment of malignant gliomas

1 reference

12 December 2020

Long-term survival in patients with supratentorial glioblastoma.

1 reference

12 December 2020

Programmed cell death in virus infections of the nervous system

1 reference

12 December 2020

Gene therapy for gliomas: molecular targets, adenoviral vectors, and oncolytic adenoviruses

1 reference

12 December 2020

Apoptosis as a cause of death in chicken embryos inoculated with Newcastle disease virus

1 reference

12 December 2020

Clinical cure of glioblastoma--two case reports

1 reference

12 December 2020

Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy

1 reference

12 December 2020

Long-term survival in cerebral glioblastoma. Case report and critical review of the literature

1 reference

12 December 2020

Immunophenotyping of childhood astrocytomas with a library of monoclonal antibodies

1 reference

12 December 2020

[Prognosis of brain tumors: epidemiology, survival time and clinical course].

1 reference

12 December 2020

Immunobiology of primary intracranial tumors. Part 7: Active immunization of patients with anaplastic human glioma cells: a pilot study

1 reference

12 December 2020

Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma

1 reference

12 December 2020

Chemotherapy and immunotherapy of malignant glioma: molecular mechanisms and clinical perspectives

1 reference

12 December 2020

Clinical Determinants of Long-Term Survival in Patients with Glioblastoma Multiforme

1 reference

12 December 2020

Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway

1 reference

12 December 2020

1 reference

12 December 2020

NEWCASTLE DISEASE VIRUS AS AN ANTINEOPLASTIC AGENT.

1 reference

12 December 2020

Spontaneous regression of neoplasms: new possibilities for immunotherapy

1 reference

12 December 2020

Training viruses to attack cancers

1 reference

12 December 2020

Genetic alterations associated with the evolution and progression of astrocytic brain tumours

1 reference

12 December 2020

Molecular pathways in the formation of gliomas.

1 reference

12 December 2020

10.1023/B:NEON.0000021735.85511.05

Identifiers

DOI

1 reference

13 May 2018

Dimensions Publication ID

1053036831

0 references

1 reference

13 May 2018